Pfizer Inc. sell Royal Bank of Canada
Start price
20.04.26
/
50%
€23.49
Target price
20.04.27
€21.27
Performance (%)
-4.24%
Price
21:50
€22.49
Summary
This prediction is currently active. With a performance of -4.24%, the SELL prediction for Pfizer Inc. by Royal_Bank_of_Canada is down slightly. This prediction currently runs until 20.04.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Pfizer Inc. | 0.361% | 0.361% |
| iShares Core DAX® | 3.762% | 3.969% |
| iShares Nasdaq 100 | 3.856% | 10.785% |
| iShares Nikkei 225® | 7.444% | 10.686% |
| iShares S&P 500 | 2.042% | 5.891% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer (PFE) had its "underperform" rating reaffirmed by Royal Bank Of Canada. They now have a $25.00 price target on the stock.
Ratings data for PFE provided by MarketBeat